SCHEMBL13927745

SCHEMBL13927745

CCOC(=O)c1ccc2[nH]nc(/C=C/c3ccc(F)cc3)c2c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
PKM P14618 1/20 0.38
KDM4E B2RXH2 5/20 0.36
HPGD P15428 4/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
HSD17B10 Q99714 2/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
AURKA O14965 1/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4137689 0.91 AURKA (0.45) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL4137691 0.91 AURKA (0.45) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL4136172 0.89 NPC1 (0.38) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL4136174 0.89 NPC1 (0.38) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL4141139 0.89 ALDH1A1 (0.37) LMNAMAPTMEN1KMT2ACYP1A2
SCHEMBL4141145 0.89 ALDH1A1 (0.37) LMNAMAPTMEN1KMT2ACYP1A2
SCHEMBL4144877 0.89 SMN1; SMN2 (0.41) MAPTNPSR1KDM4EHPGDALDH1A1
SCHEMBL4144873 0.89 SMN1; SMN2 (0.41) MAPTNPSR1KDM4EHPGDALDH1A1
SCHEMBL4146502 0.88 ALDH1A1 (0.37) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL4146508 0.88 ALDH1A1 (0.37) LMNAMAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND CNKSR1, NR3C2, CSNK2B LMNA 3403/4885MAPT 2811/4885MEN1 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.